Our mission is to prevent cancer mortality through earlier detection and closer monitoring of disease.
Location: Sweden, Stockholm
Employees: 11-50
Total raised: $27.63M
Founded date: 2017
Investors 6
| Date | Name | Website |
| - | Bonnier Ca... | bonniercap... |
| - | Navigare V... | navigareve... |
| - | Norrsken V... | norrsken.v... |
| - | Industrifo... | industrifo... |
| - | SUP46 | SUP46.com/ |
| - | Chalmers V... | chalmersve... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 25.06.2022 | Series A | $21M | - |
| 23.01.2020 | Seed | $6.63M | - |
Mentions in press and media 12
| Date | Title | Description | Source |
| 08.04.2024 | Elypta interim study LEVANTIS-0087A results show glycosamino... | Elypta interim study LEVANTIS-0087A results show glycosaminoglycan's potential to predict the risk o... | news.cisio... |
| 06.07.2023 | Elypta - Multi Cancer Early Detection Company Developing Fir... | Elypta - Multi Cancer Early Detection Company Developing First GAGome -Based Tests - Receives ISO 13... | news.cisio... |
| 15.03.2023 | Study in JCO Precision Oncology shows promising results supp... | Study in JCO Precision Oncology shows promising results supporting the use of glycosaminoglycan prof... | news.cisio... |
| 07.12.2022 | Double multi-cancer detection rate shown in the earliest sta... | Double multi-cancer detection rate shown in the earliest stage using Elypta MIRAM® kit Wed, Dec 07, ... | news.cisio... |
| 10.08.2022 | Elypta appoints Volker Liebenberg as CMO | Elypta appoints Volker Liebenberg as CMO Wed, Aug 10, 2022 08:00 CET Report this content Stockholm, ... | news.cisio... |
| 20.06.2022 | Elypta raises $21 million Series A to develop metabolism-bas... | Elypta raises $21 million Series A to develop metabolism-based multi-cancer early detection test Mon... | news.cisio... |
| 20.06.2022 | Elypta raises $21 million Series A to develop metabolism-bas... | Today we are happy to announce our continued support and investment in Elypta – a Swedish diagnostic... | industrifo... |
| 20.06.2022 | Elypta raises $21 million Series A to develop metabolism-bas... | Elypta, a Swedish diagnostics company aiming to commercialize the first metabolism-based liquid biop... | navigareve... |
| 15.02.2022 | Elypta launches Multi-Cancer Early Detection screening study... | Elypta launches Multi-Cancer Early Detection screening study measuring metabolic GAGome levels in as... | news.cisio... |
| 08.12.2021 | Elypta extends range of GAGome-based liquid biopsy applicati... | Elypta extends range of GAGome-based liquid biopsy applications San Raffaele initiates new AUR93A mu... | news.cisio... |
Show more